Table 1.
Study Title* | Statistical Design Features | Statistical Analysis Features |
---|---|---|
Active Randomized Clinical Trials | ||
Hydrocortisone for BPD |
Powered for joint evaluation of efficacy conditional on safety |
Two-stage sequential evaluation of efficacy conditional on safety |
Late Hypothermia | RCT stratified by age of enrollment and level of encephalopathy |
Bayesian interim monitoring for safety, futility, and efficacy Bayesian analysis of final outcomes for treatment benefit |
MILK Trial | RCT stratified by birth weight (BW), center and feeding group eligibility Simulations for operating characteristics |
Linear regression to estimate the adjusted mean difference in cognitive scaled scores between the two treatment groups |
NEC Surgery Trial (NEST) |
Comprehensive cohort design Randomization stratified by predicted baseline risk |
Meta-analysis of randomized and preference cohorts after propensity modeling/adjustment in the latter |
Optimizing Cooling |
2×2 factorial design with stratified randomization |
Marginal and within-table adjusted analyses |
Transfusion of Prematures (TOP) |
Pragmatic RCT with stratified randomization and pilot study of blood bank variations |
Survival analyses of death Longitudinal modeling of growth Economic evaluation |
Hydrocortisone for Cardiovascular Insufficiency |
Randomized, multicenter, double- blind, placebo-controlled trial Patients are enrolled and randomized in a variable block design, 1:1 ratio of hydrocortisone or placebo |
Planned sample size reanalysis after 1 year of enrollment based on overall outcome rate |
Preemie Hypothermia |
RCT stratified by age of enrollment and level of encephalopathy |
Bayesian interim monitoring for safety, futility, and efficacy Bayesian analysis of final outcomes for treatment benefit |
Incubator Weaning |
RCT stratified by center and gestational age |
Median regression adjusting for the trial stratification factors |
Inositol RCT | RCT stratified by center and gestational age |
Separate analyses plans for publication and FDA submission |
Completed Randomized Clinical Trials | ||
Early BP Pilot | Time-limited feasibility pilot study with 2×2 factorial design |
Feasibility analyses |
Vitamin E Pilot | Pilot, double-blind placebo- controlled RCT |
Analyses of Vitamin E levels over time |
SUPPORT | 2×2 factorial design, randomization stratified by site and GA groups |
Marginal outcomes analyses Interim group sequential monitoring in factorial setup Familial clustering |
Inositol Multidose Trial |
Double-blind phase II trial conducted under IND from FDA in three treatment groups stratified by GA |
PK modeling allowing for endogenous Inositol synthesis and change from IV to oral administration during the intervention Used to establish dosage for pivotal phase III trial |
Phototherapy | RCT stratified by site and BW groups |
Primary outcome at 18 months (used surrogate markers for interim safety/efficacy monitoring) |
Registry Studies | ||
Generic Data Base (GDB) |
Registry of all NRN very low BW births |
Varied analytic approaches, including multiple regression, Classification and Regression Trees, longitudinal analyses, multilevel hierarchical generalized linear models, prediction modeling, and genetic epidemiology analyses |
22–26 Month Follow-Up |
Registry of all NRN extremely low BW outcomes at 18 months |
|
Moderate Preterm Registry |
Registry of moderate preterm births | |
Term Control Registry |
||
Active Observational Studies | ||
ALPS aEEG | Prospective, cohort study | |
Early Onset Sepsis II |
Surveillance study | Incidence/prevalence rates |
Completed Observational Studies | ||
Term Hypotension | Observational, time-limited study | Linear and logistic regression |
Early Blood Pressure |
Observational, time-limited study | BP profiles analyses |
Early Onset Sepsis | Surveillance study | Incidence/prevalence rates |
Preemie aEEG | Prospective cohort study Sample size based on false- negative rate |
Interobserver reliability modeling Prediction modeling |
Candida | Prospective cohort study | Likelihood ratio–based risk stratification, latent class analyses for diagnostic tests |
PCV-7 | Vaccine efficacy study | Multiple linear/logistic regression for geometric mean titers |